JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 22nd
-
Intra-Cellular Therapies to Present at the JMP Securities Life Sciences Conference
-
Tetraphase Pharmaceuticals to Present at 2016 JMP Securities Life Sciences Conference
-
JMP Securities Downgrades Infinity Pharmaceutical (INFI) to Market Perform
-
Karyopharm to Present at the 2016 JMP Securities Life Science Conference
-
Halyard Health, Inc. to Present at JMP Securities Life Sciences Conference
-
Axcella to Present at the JMP Securities Life Sciences Conference
-
AVEO to Present at the 2016 JMP Securities Life Science Conference
-
Nivalis Therapeutics to Present at the JMP Securities Life Sciences Conference
-
Compugen to Present at JMP Securities Life Sciences Conference in New York
-
BioLineRx to Present at the JMP Securities Life Sciences Conference in New York
-
JMP Securities Downgrades Marketo, Inc (MKTO) to Market Perform
-
Minerva Neurosciences to Present at JMP Securities Life Sciences Conference June 21, 2016
-
Minerva Neurosciences to Present at JMP Securities Life Sciences Conference June 21, 2016
-
Vitae Pharmaceuticals to Present at JMP Securities Life Sciences Conference
-
Cytokinetics to Participate in Upcoming Investor Conferences
-
Depomed to Present at the JMP Securities Life Sciences Conference
-
Maiden Holdings, Ltd. Announces Closing of $110 Million 6.625% Notes due June 14, 2046
-
Minerva Neurosciences (NERV) Prices 5.26M Common Stock Offering at $9.50/Share
-
Minerva Neurosciences Announces Pricing of Public Offering of Common Stock
-
Tractor Supply Expands Revionics Usage with Markdown Optimization, Renews License Agreement through 2019
-
Pieris Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
-
RaNA Therapeutics to Present at Upcoming Conferences
-
Conatus to Present at JMP Securities Life Sciences Conference
-
Strongbridge Biopharma plc to Participate in the JMP Securities Life Sciences Conference and 3rd Annual ROTH Healthcare Day in London
-
Cerulean to Present at JMP Securities Life Sciences Conference
-
Nabriva to Present at the JMP Securities Life Sciences Conference
-
Syndax Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
-
Neos Therapeutics CEO to Present at JMP Securities Life Sciences Conference on June 21, 2016
-
Loxo Oncology to Present at the JMP Securities Life Sciences Conference
-
Nevro Announces Full Exercise of Over-Allotment Option and Closing of Public Offering of $172.5 Million Convertible Senior Notes
-
Ocera to Present at the JMP Securities Life Sciences Conference
-
Minerva Neurosciences (NERV) to Offer Undisclosed Amount of Common Stock
-
Minerva Neurosciences Announces Proposed Public Offering of Common Stock
-
Minerva Neurosciences Announces Proposed Public Offering of Common Stock
-
K2M Group Holdings, Inc. to Present at the JMP Securities Life Sciences Conference 2016
-
Revionics Congratulates Rouses' Allison Rouse-Royster, Winner of Progressive Grocer's 2016 Top Women in Grocery Award
-
Axsome Therapeutics to Present at the 2016 JMP Securities Life Sciences Conference
-
Nevro to Present at the JMP Securities Life Sciences Conference
-
Presbia to Participate in JMP Securities Life Science Conference 2016 in New York
-
BioQ Pharma to Present at the JMP Securities Life Sciences Conference
-
Hydra Biosciences to Present at the JMP Securities Life Sciences Conference on June 22
-
Novocure to Present at JMP Securities 2016 Life Sciences Conference
-
Nevro Announces Pricing of Public Offering of $150 Million Convertible Senior Notes
-
Maiden Holdings, Ltd. Announces Pricing of $110 Million Offering of 6.625% Notes due June 14, 2046
-
Idera to Present at Two June Investor Healthcare Conferences
-
Revionics to Present at Baird 2016 Consumer, Technology & Services Conference on "Retail Redefined: Why Pricing is Still King"
-
Forward Pharma CFO to Participate in Two Investor Conferences in June
-
Notable Analyst Rating Changes 6/6: (RF) (WFT) (WMT) Upgraded; (ABBV) (CUDA) (HOG) Downgraded
-
JMP Securities Downgrades Barracuda Networks (CUDA) to Market Underperform

